Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) closed at $58.97 up 2.76% from its previous closing price of $57.38. In other words, the price has increased by $2.76 from its previous closing price. On the day, 0.56 million shares were traded.
Ratios:
For a deeper understanding of Rhythm Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.13 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 13.60 whereas as Long-Term Debt/Eq ratio is at 13.50.
On January 02, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $80.Jefferies initiated its Buy rating on January 02, 2025, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 29 ’25 when Cramer Pamela J. sold 7,031 shares for $65.09 per share. The transaction valued at 457,663 led to the insider holds 19,209 shares of the business.
Mazabraud Yann sold 6,745 shares of RYTM for $438,946 on Apr 29 ’25. The EVP, Head of International now owns 37,655 shares after completing the transaction at $65.08 per share. On Apr 29 ’25, another insider, YANN MAZZABRAUD, who serves as the Officer of the company, bought 6,745 shares for $64.41 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 27.41 while its Price-to-Book (P/B) ratio in mrq is 197.60.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $68.58, while it has fallen to a 52-week low of $35.17. The 50-Day Moving Average of the stock is 4.09%, while the 200-Day Moving Average is calculated to be 8.60%.
Shares Statistics:
A total of 63.49M shares are outstanding, with a floating share count of 57.29M. Insiders hold about 9.96% of the company’s shares, while institutions hold 95.09% stake in the company.
